Structured exercise program following adjuvant chemotherapy for colon cancer: A cost-utility analysis of the CHALLENGE trial
PURPOSE: The phase III CHALLENGE trial (CCTG CO.21) demonstrated that a 3-year structured exercise program (SEP) improved disease-free and overall survival versus health education materials (HEM) in patients with stage III or high-risk stage II colon cancer after surgery and adjuvant chemotherapy. We assessed the cost-effectiveness of the SEP versus HEM. METHODS: This pre-specified economic evaluation used prospectively collected data from all trial participants (n = 889). The base case adopted the Canadian public payer perspective and included direct healthcare costs over a 5-year time horizon with a 1.5% discount rate. 36-Item Short Form (SF-36) outcomes were mapped to Short-Form 6-Dimension (SF-6D) utilities using a validated algorithm. Mean costs (2024 CAD) and effects (life-years (LYs) and quality-adjusted life-years (QALYs)) per participant in each intervention group were used to estimate the incremental costs, incremental LYs/QALYs, incremental cost-effectiveness ratio (ICER, $/life-year gain (LYG)), and incremental cost-utility ratio (ICUR, $/QALY) when applicable. Uncertainty was assessed via bootstrapping (1,000 samples). Notable scenario analyses included a 10-year time horizon and a societal perspective incorporating lost wages due to missed work, measured through the Work Productivity and Activity Impairment questionnaire. RESULTS: In the base case, despite an up-front cost of $2,917 to provide the exercise sessions, the SEP ($31,957) was dominant over HEM ($33,546), being less costly (-$1,589) and more effective (+0.05 LYs; +0.10 QALYs). The SEP was dominant in 53% of bootstrap samples, and 80% fell below a $50,000 per QALY willingness-to-pay threshold. Major cost drivers were cancer recurrence or new malignancy and anticancer therapy. Scenario analyses were consistent with the base case. CONCLUSION: The SEP was less costly and more effective than HEM. This study can inform payers and health-systems with implementation of SEPs in routine care.
Authors
- Patti O’Brien
- Patricia A. Tang (ORCID: https://orcid.org/0000-0003-1497-8539)
- Matthew C. Cheung (ORCID: https://orcid.org/0000-0003-3193-5872)
- S. Clarke
- Neil Chua (ORCID: https://orcid.org/0000-0002-0093-7480)
- K S Courneya
- Dongsheng Tu (ORCID: https://orcid.org/0000-0003-4842-2184)
- Derek J. Jonker (ORCID: https://orcid.org/0009-0008-1103-3429)
- Sharlene Gill (ORCID: https://orcid.org/0000-0003-3306-3617)
- Ralph Wong
- Matthew E. Burge
- John Raymond Zalcberg
- Christine Friedenreich
- Ralph M. Meyer
- Christopher J. O'Callaghan
- Howard J. Lim
- Haryana M. Dhillon (ORCID: https://orcid.org/0000-0003-4039-5169)
- Shahid Ahmed (ORCID: https://orcid.org/0000-0002-2099-698X)
- Victoria Coyle (ORCID: https://orcid.org/0000-0001-9566-4130)
- Michael Brundage (ORCID: https://orcid.org/0000-0002-5104-0497)
- Annette E. Hay (ORCID: https://orcid.org/0000-0003-4581-3390)
- Kelvin KW. Chan (ORCID: https://orcid.org/0000-0002-2501-3057)
- Ryan WK. Chu (ORCID: https://orcid.org/0000-0001-8927-8727)
- Rebecca KS. Wong (ORCID: https://orcid.org/0000-0001-7210-3330)
- Christopher M. Booth (ORCID: https://orcid.org/0000-0002-1353-3653)
- Janette L. Vardy (ORCID: https://orcid.org/0000-0002-5739-5790)
Institutions
- Queen's University Belfast (GB)
- Alberta Health Services (CA)
- The University of Sydney (AU)
- Sunnybrook Health Science Centre (CA)
- University of British Columbia (CA)
- University of Alberta (CA)
- The University of Queensland (AU)
- University of Calgary (CA)
- University of Toronto (CA)
- Queen's University (CA)
- Royal Brisbane and Women's Hospital (AU)
- Concord Repatriation General Hospital (AU)
- St. Boniface Hospital (CA)
- Ottawa Hospital (CA)
- Health Sciences Centre (CA)
- Princess Margaret Cancer Centre (CA)
- CancerCare Manitoba (CA)
- Cooperative Trials Group for Neuro-Oncology (AU)
- Saskatchewan Cancer Agency (CA)
- Alfred Health (AU)
- Monash University (AU)
- McMaster University (CA)
Publication Details
- Journal
- Journal of Clinical Oncology
- Published
- 2026-05-31
- DOI
- https://doi.org/10.1200/jco-26-00765
- Primary Topic
- Cancer survivorship and care
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Ottawa Hospital Research Institute